Despite the Covid-19 epidemic, Marchesini Group has never stopped. The company is part of the packaging supply chain included by the Italian government as among the essential activities that remain open. At this time, as well as guaranteeing customer order delivery with the help of technologies such as FAT in streaming, the Group is also producing and delivering packaging machines for vaccines. Marchesini Group is the first company in the world to create complete lines for the packaging of these important products from the pharmaceutical industry. In 2004, a well known Chinese company commissioned a line that would carry out the whole process of filling and packaging vaccines in a syringe. A few years later, in 2009, that customer became the first Chinese big pharma company to receive the authorization for the production of a vaccine against the H1N1 virus that caused swine flu. The valuable collaboration has continued and today Marchesini Group is in the process of delivering three additional vaccine packaging lines and other stand-alone machines to update existing lines.
The Italian Company is also been pioneers in this field in the rest of Southeast Asia, with the installation of a vaccine line capable of filling, assembling and packing syringes. The line, in operation for five years, represented an important step forward for the local market in the production of vaccines in syringes, which are usually expensive for emerging countries.
Technologies by Marchesini have also allowed the Group to meet the requests for lines by some pharmaceutical multinationals involved in the production of antibiotics against the H5N1 virus, responsible for avian influenza.
“We will try, even in this particular moment in history, to be as quick as possible in delivering our machines, while respecting the health of our collaborators and the technical timing,” said Pietro Cassani, CEO of Marchesini Group in some interviews given to RAI, Italian state television.
In Italy, where the production plants of Marchesini are located, the company has recently doubled the production department of Corima, the Group’s division dedicated to aseptic packaging technology and machines. Today, Corima has a 12,000 square metre factory at its disposal and aims to respond more completely and quickly to the growing demands of a sector that, considering recent events, is more than active than ever.